Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis.

Yusi ChenFang LiJun LuoJingyuan ChenPeng LuoJiang Li

Published in: Canadian respiratory journal (2021)

Analysis revealed positive advantages for the use of PAH-targeted drugs in patients with CTEPH. Overall, treprostinil and riociguat were superior to all other PAH-targeted medications in most of the outcomes investigated.

Keyphrases

pulmonary hypertension
pulmonary arterial hypertension
cancer therapy
pulmonary artery
polycyclic aromatic hydrocarbons
atrial fibrillation
single cell
type diabetes
atomic force microscopy
drug delivery
metabolic syndrome
coronary artery
mass spectrometry
skeletal muscle